Cell & Tissue Preservation Market to Grow at a Robust CAGR of 11.9% from 2022 to 2030

Implementation of Risk-mitigation Strategies at Fertility Centers amidst COVID-19 Pandemic

The reopening of fertility care services in the midst of the COVID-19 pandemic lead to numerous concerns that need immediate addressing. Companies in the cell & tissue preservation market are gaining awareness about these concerns to prevent the risk of cross-contamination and transmission at the fertility centers. Due to the novelty of the disease, there is a need for more information confirming an association of coronavirus with reproductive tissues, embryos, and gametes.

Cryobanking, being an essential service in fertility preservation, is linked with the risk of cross-contamination through the cryogenic mediums. Stakeholders are increasing research to find possible sources of cross-contamination through liquid nitrogen.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111515

Ice-related Damage in Tissues Creates Drawbacks in Cryopreservation

Cryopreservation holds potential to strongly benefit several areas of medicine by increasing the ease with which therapeutic cells, tissues, and organs can be stored. However, it has been found that extracellular ice directly damages tissues, either by puncturing or crushing cell membranes or by disrupting extracellular structures. In order to reduce the extent of ice-related damage, stakeholders are making use of cryopreservation protocols such as the CPAs (cryoprotective agents).

CPAs help to reduce the concentration of electrolytes and ice formation by hydrogen bonding with water molecules to prevent them from bonding to ice crystals. CPAs capable of crossing cell membranes are crucial in cryopreservation. The use of such molecules, termed penetrating CPAs (pCPAs), can substantially reduce cryoinjury.

Application of Oxygen in Preservation of Transplant Organs Gains Popularity

The cell & tissue preservation market is projected to grow at a robust CAGR of 11.9% from 2021 to 2031. Giner Life Sciences – a privately-held company focused on the development and commercialization of oxygenated cell therapies, is pursuing new approaches in the application of oxygen for the preservation of transplant organs and clusters of cells inside implantable capsules. Companies in the cell & tissue preservation market are taking cues from such innovative approaches to develop transportation devices for a donated pancreas organ, which incorporates an on-demand oxygen generator.

View full report@ https://qyresearchmedical.com/report/cell-tissue-preservation-market-type-cells-and-tissues-application-therapeutics-research-development-drug-discovery-and-others-product-equipment-bio-preservation-media-and-software-and-end-user-biob-2021-2031/111515

Transportation device incorporating an on-demand oxygen generator holds potential to supply oxygen to the vasculature of the pancreas as soon as possible after it is donated.

Toxicity of DMSO Leads to Innovations in Biomimetic Materials

There is a need for mid-range automation for cryopreservation. Companies in the cell & tissue preservation market are innovating in robot in order to meet this demand. Though dimethyl sulfoxide (DMSO) is considered as the gold standard for cryopreservation of mammalian cells and tissues, certain concentrations of DMSO can be toxic to cells. Thus, to mitigate potential toxicity problems, companies in the cell & tissue preservation market are increasing research on using different combinations of cryoprotective agents such as supplementing a lower concentration of DMSO with the glycerol or polypropylene glycol.

Moreover, companies are increasing efforts to introduce alternatives to DMSO such as biomimetic materials that are called the antifreeze protein or an ice-binding protein.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111515/2900

Analysts’ Viewpoint

Companies in the cell & tissue preservation market are adopting strategies to reduce the risks of cross-contamination at fertility centers, especially for oncofertility, amid the COVID-19 pandemic.. The cell & tissue preservation market is expected to reach US$ 10.04 Bn by 2031. However, one of the main limitations of current cryopreservation methods is the recovery rate of cells after freezing. Hence, companies should increase research in antifreeze proteins that have the potential to mimic the properties of synthetic polymers in cryopreservation methods. In addition, transportation devices incorporating on-demand oxygen generator are being publicized for use in organ transplant applications.

Cell & Tissue Preservation Market: Overview

Cell & tissue banks are biorepositories for the preservation of human and animal cells & tissues utilized for biodiversity studies, disease diagnosis, and research. These banks assist in the storage of various types of tissue samples such as bone, skin, cornea, heart valves, umbilical cord, and human soft tissues.

Cell & tissue banks vary significantly in size, with cell & tissue banks in medical institutions storing a moderate number of samples, while national tissue banks store a large number of samples. These samples are utilized to support research, particularly studies in personalized medicine, genetic disorders, and stem cell research to treat genetic conditions and maintain and update age demographic databases.

Increasing demand for regenerative medicines is a significant factor driving the global cell & tissue preservation market. These medicines are capable of replacing, engineering, and regenerating functional cells, tissues for treating tissue loss due to age-related diseases or conditions, diseases, major injury, or congenital defects.

Other vital factors driving the market include increasing prevalence of cardiovascular and neurological disorders, a variety of cancers, diabetes, and other diseases

Increasing need for storage of organs for transplant and research of new patient medicines in research center initiatives by healthcare organizations to improvise healthcare facilities are anticipated to fuel the global cell & tissue preservation market

Market Segmentation: Cell & Tissue Preservation Market

In terms of type, the global cell & tissue preservation market has been classified into cells and tissues. Cells have been split into mammalian cells & others (microorganisms and plant cells). The tissues segment has been categorized into blood, bone, soft tissues, skin, and others. Rise in investments in the field of regenerative medicine research is estimated to propel the market. Human blood, tissues, cells, and organs own the capability to heal damaged tissues and organs with long-term advantages.

Based on application, the global cell & tissue preservation market has been divided into therapeutics, research & development, drug discovery, and others. Tissues preserved in tissue banks could be utilized to fulfill a variety of medical needs of people. For instance, heart valves can be used in patients with heart disorders; corneal transplantation can be used to provide vision to blind people; tendons and ligaments can be used in orthopedic surgery; and blood can be employed to treat blood disorders.

In terms of product, the global cell & tissue preservation market has been divided into equipment, bio preservation media, and software. The equipment segment has been further sub-segmented into freezers, thawing equipment, refrigerators, storage systems, and others. While the bio preservation media segment has been further classified into home-brew media and pre-formulated media. In terms of equipment type, the cryopreservation systems segment dominated the market in 2020. Cryopreservation is the process of cooling followed by storage of frozen cells to provide a continuous supply of genetically stable living cells by inhibiting all biochemical activities that are to be used for procedures such as organ donation, bone marrow transplant, and others.

Based on end user, the global cell & tissue preservation market has been segmented into biobanks, hospitals, and others. Biobanks store numerous different types of biospecimens, ranging from cells and small tissue samples right through to whole organs, whole limbs, or even whole bodies. Cells and small biospecimens could be flash frozen in cryoprotectant solutions and stored in liquid nitrogen to preserve their structure and function.

Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The cell & tissue preservation market report provides current and expected revenue (US$ Mn) for each of these segments from 2021 to 2031, considering 2020 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2021 to 2031, along with market size estimations.

Regional Overview: Cell & Tissue Preservation Market

In terms of region, the global cell & tissue preservation market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.

The current and expected market value (US$ Mn) of these regional markets and their major countries have been provided in the report from 2021 to 2031, with their CAGRs from 2021 to 2031

The study also offers a list of recommendations, highlights, and useful insights of the global cell & tissue preservation market, which would help new companies willing to enter the market and existing companies to increase market shares and in the decision-making process

Major Players

The cell & tissue preservation market report concludes with the company profiles section, which includes key information about major players in the global cell & tissue preservation market

Leading players analyzed in the report include

  • Thermo Fisher Scientific, Inc.
  • Lonza
  • BD
  • Merck KGaA
  • Cytiva
  • Agilent Technologies, Inc.
  • Avantor, Inc.
  • FUJIFILM Irvine Scientific
  • BioLifeSolutions Inc.
  • AMSBIO
  • Princeton CryoTech
  • STEMCELL Technologies Inc.
  • LGC SeraCare
  • Corning Incorporated
  • CellGenix GmbH

Each of these players has been profiled in the cell & tissue preservation market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Key Questions Answered in Cell & Tissue Preservation Market Report

  • What is the sales/revenue generated by the cell & tissue preservation market across all regions during the forecast period?
  • What are the opportunities in the global cell & tissue preservation market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which product segment is expected to generate the highest revenue globally in 2030?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Cell & Tissue Preservation Market – Segmentation

Type

  • Cells
  • Mammalian Cells
  • Others (Microorganisms and Plant Cells)
  • Tissues
  • Blood
  • Bone
  • Soft Tissues
  • Skin
  • Others

Product

  • Software
  • Equipment
  • Freezers
  • Refrigerators
  • Storage Systems
  • Others
  • Bio Preservation Media
  • Home-brew Media
  • Pre-formulated Media

End User

  • Biobanks
  • Hospitals
  • Others

Application

  • Therapeutics
  • Research & Development
  • Drug Discovery
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Cell & Tissue Preservation Market

4. Market Overview

4.1. Introduction

4.1.1. Type Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Cell & Tissue Preservation Market Analysis and Forecast, 2017–2031

5. Key Insights

5.1. Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.)

5.2. COVID-19 Pandemic Impact on Industry (value chain and short-/ mid-/ long-term impact)

5.3. Process Analysis

5.4. Top companies operating in Market Space

5.5. Applications of cell & tissue culture in drug development

5.6. Technological Advancements

6. Global Cell & Tissue Preservation Market Analysis and Forecast, by Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

6.3.1. Cells

6.3.1.1. Mammalian Cells

6.3.1.2. Others (microorganisms and plant cells)

6.3.2. Tissues

6.3.2.1. Blood

6.3.2.2. Bone

6.3.2.3. Soft Tissues

6.3.2.4. Skin

6.3.2.5. Others

6.4. Global Cell & Tissue Preservation Market Attractiveness, by Type

7. Global Cell & Tissue Preservation Market Analysis and Forecast, by Application

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

7.3.1. Therapeutics

7.3.2. Research & Development

7.3.3. Drug Discovery

7.3.4. Others (Cosmetics and Clinical trials)

7.4. Global Cell & Tissue Preservation Market Attractiveness, by Application

8. Global Cell & Tissue Preservation Market Analysis and Forecast, by Product

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Global Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

8.3.1. Equipment

8.3.1.1. Freezers

8.3.1.2. Thawing Equipment

8.3.1.3. Refrigerators

8.3.1.4. Storage Systems

8.3.1.5. Others

8.3.2. Bio preservation media

8.3.2.1. Home-brew media

8.3.2.2. Pre-formulated media

8.3.3. Software

8.4. Global Cell & Tissue Preservation Market Attractiveness, by Product

9. Global Cell & Tissue Preservation Market Analysis and Forecast, by End-user

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Global Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

9.3.1. Biobanks

9.3.2. Hospitals

9.3.3. Others

9.4. Global Cell & Tissue Preservation Market Attractiveness, by End-user

10. Global Cell & Tissue Preservation Market Analysis and Forecast, by Region

10.1. Key Findings

10.2. Global Cell & Tissue Preservation Market Value Forecast, by Region

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Global Cell & Tissue Preservation Market Attractiveness, by Region

11. North America Cell & Tissue Preservation Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. North America Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

11.2.1. Cells

11.2.1.1. Mammalian Cells

11.2.1.2. Others (microorganisms and plant cells)

11.2.2. Tissues

11.2.2.1. Blood

11.2.2.2. Bone

11.2.2.3. Soft Tissues

11.2.2.4. Skin

11.2.2.5. Others

11.3. North America Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

11.3.1. Therapeutics

11.3.2. Research & Development

11.3.3. Drug Discovery

11.3.4. Others (Cosmetics and Clinical trials)

11.4. North America Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

11.4.1. Equipment

11.4.1.1. Freezers

11.4.1.2. Thawing Equipment

11.4.1.3. Refrigerators

11.4.1.4. Storage Systems

11.4.1.5. Others

11.4.2. Bio preservation media

11.4.2.1. Home-brew media

11.4.2.2. Pre-formulated media

11.4.3. Software

11.5. North America Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

11.5.1. Biobanks

11.5.2. Hospitals

11.5.3. Others

11.6. North America Cell & Tissue Preservation Market Value Forecast, by Country, 2017–2031

11.6.1. U.S.

11.6.2. Canada

11.7. North America Cell & Tissue Preservation Market Attractiveness Analysis

11.7.1. By Type

11.7.2. By Application

11.7.3. By Product

11.7.4. By End-user

11.7.5. By Country

12. Europe Cell & Tissue Preservation Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Europe Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

12.2.1. Cells

12.2.1.1. Mammalian Cells

12.2.1.2. Others (microorganisms and plant cells)

12.2.2. Tissues

12.2.2.1. Blood

12.2.2.2. Bone

12.2.2.3. Soft Tissues

12.2.2.4. Skin

12.2.2.5. Others

12.3. Europe Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

12.3.1. Therapeutics

12.3.2. Research & Development

12.3.3. Drug Discovery

12.3.4. Others (Cosmetics and Clinical trials)

12.4. Europe Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

12.4.1. Equipment

12.4.1.1. Freezers

12.4.1.2. Thawing Equipment

12.4.1.3. Refrigerators

12.4.1.4. Storage Systems

12.4.1.5. Others

12.4.2. Bio preservation media

12.4.2.1. Home-brew media

12.4.2.2. Pre-formulated media

12.4.3. Software

12.5. Europe Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

12.5.1. Biobanks

12.5.2. Hospitals

12.5.3. Others

12.6. Europe Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Europe Cell & Tissue Preservation Market Attractiveness Analysis

12.7.1. By Type

12.7.2. By Application

12.7.3. By Product

12.7.4. By End-user

12.7.5. By Country/Sub-region

13. Asia Pacific Cell & Tissue Preservation Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

13.2.1. Cells

13.2.1.1. Mammalian Cells

13.2.1.2. Others (microorganisms and plant cells)

13.2.2. Tissues

13.2.2.1. Blood

13.2.2.2. Bone

13.2.2.3. Soft Tissues

13.2.2.4. Skin

13.2.2.5. Others

13.3. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

13.3.1. Therapeutics

13.3.2. Research & Development

13.3.3. Drug Discovery

13.3.4. Others (Cosmetics and Clinical trials)

13.4. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

13.4.1. Equipment

13.4.1.1. Freezers

13.4.1.2. Thawing Equipment

13.4.1.3. Refrigerators

13.4.1.4. Storage Systems

13.4.1.5. Others

13.4.2. Bio preservation media

13.4.2.1. Home-brew media

13.4.2.2. Pre-formulated media

13.4.3. Software

13.5. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

13.5.1. Biobanks

13.5.2. Hospitals

13.5.3. Others

13.6. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031

13.6.1. China

13.6.2. Japan

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis

13.7.1. By Type

13.7.2. By Application

13.7.3. By Product

13.7.4. By End-user

13.7.5. By Country/Sub-region

14. Latin America Cell & Tissue Preservation Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Latin America Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

14.2.1. Cells

14.2.1.1. Mammalian Cells

14.2.1.2. Others (microorganisms and plant cells)

14.2.2. Tissues

14.2.2.1. Blood

14.2.2.2. Bone

14.2.2.3. Soft Tissues

14.2.2.4. Skin

14.2.2.5. Others

14.3. Latin America Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

14.3.1. Therapeutics

14.3.2. Research & Development

14.3.3. Drug Discovery

14.3.4. Others (Cosmetics and Clinical trials)

14.4. Latin America Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

14.4.1. Equipment

14.4.1.1. Freezers

14.4.1.2. Thawing Equipment

14.4.1.3. Refrigerators

14.4.1.4. Storage Systems

14.4.1.5. Others

14.4.2. Bio preservation media

14.4.2.1. Home-brew media

14.4.2.2. Pre-formulated media

14.4.3. Software

14.5. Latin America Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

14.5.1. Biobanks

14.5.2. Hospitals

14.5.3. Others

14.6. Latin America Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Market Attractiveness Analysis

14.7.1. By Type

14.7.2. By Application

14.7.3. By Product

14.7.4. By End-user

14.7.5. By Country

15. Middle East & Africa Cell & Tissue Preservation Market Analysis and Forecast

15.1. Introduction

15.1.1. Key Findings

15.2. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

15.2.1. Cells

15.2.1.1. Mammalian Cells

15.2.1.2. Others (microorganisms and plant cells)

15.2.2. Tissues

15.2.2.1. Blood

15.2.2.2. Bone

15.2.2.3. Soft Tissues

15.2.2.4. Skin

15.2.2.5. Others

15.3. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

15.3.1. Therapeutics

15.3.2. Research & Development

15.3.3. Drug Discovery

15.3.4. Others (Cosmetics and Clinical trials)

15.4. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

15.4.1. Equipment

15.4.1.1. Freezers

15.4.1.2. Thawing Equipment

15.4.1.3. Refrigerators

15.4.1.4. Storage Systems

15.4.1.5. Others

15.4.2. Bio preservation media

15.4.2.1. Home-brew media

15.4.2.2. Pre-formulated media

15.4.3. Software

15.5. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

15.5.1. Biobanks

15.5.2. Hospitals

15.5.3. Others

15.6. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Rest of Middle East & Africa

15.7. Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis

15.7.1. By Type

15.7.2. By Application

15.7.3. By Product

15.7.4. By End-user

15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Share Analysis, by Company (2019)

16.2. Company Profiles

16.2.1. Thermo Fisher Scientific, Inc.

16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.1.2. Product Portfolio

16.2.1.3. SWOT Analysis

16.2.1.4. Strategic Overview

16.2.2. Lonza

16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.2.2. Product Portfolio

16.2.2.3. SWOT Analysis

16.2.2.4. Strategic Overview

16.2.3. BD

16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.3.2. Product Portfolio

16.2.3.3. SWOT Analysis

16.2.3.4. Strategic Overview

16.2.4. Merck KGaA

16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.4.2. Product Portfolio

16.2.4.3. SWOT Analysis

16.2.4.4. Strategic Overview

16.2.5. Cytiva

16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.5.2. Product Portfolio

16.2.5.3. SWOT Analysis

16.2.5.4. Strategic Overview

16.2.6. Agilent Technologies, Inc.

16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.6.2. Product Portfolio

16.2.6.3. SWOT Analysis

16.2.6.4. Strategic Overview

16.2.7. Avantor, Inc.

16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.7.2. Product Portfolio

16.2.7.3. SWOT Analysis

16.2.7.4. Strategic Overview

16.2.8. FUJIFILM Irvine Scientific.

16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.8.2. Product Portfolio

16.2.8.3. SWOT Analysis

16.2.8.4. Strategic Overview

16.2.9. BioLifeSolutions Inc.

16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.9.2. Product Portfolio

16.2.9.3. SWOT Analysis

16.2.9.4. Strategic Overview

16.2.10. AMSBIO

16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.10.2. Product Portfolio

16.2.10.3. SWOT Analysis

16.2.10.4. Strategic Overview

16.2.11. Princeton CryoTech

16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.11.2. Product Portfolio

16.2.11.3. SWOT Analysis

16.2.11.4. Strategic Overview

16.2.12. STEMCELL Technologies Inc.

16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.12.2. Product Portfolio

16.2.12.3. SWOT Analysis

16.2.12.4. Strategic Overview

16.2.13. LGC SeraCare

16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.13.2. Product Portfolio

16.2.13.3. SWOT Analysis

16.2.13.4. Strategic Overview

16.2.14. Corning Incorporated

16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.14.2. Product Portfolio

16.2.14.3. SWOT Analysis

16.2.14.4. Strategic Overview

16.2.15. CellGenix GmbH

16.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.15.2. Product Portfolio

16.2.15.3. SWOT Analysis

16.2.15.4. Strategic Overview

16.2.16. Others

16.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.16.2. Product Portfolio

16.2.16.3. SWOT Analysis

16.2.16.4. Strategic Overview

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111515/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi